UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

Diabetes, obesity & metabolism, 2013-02, Vol.15 (2), p.175-184

2013

Volltextzugriff (PDF)

Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function

Diabetes, obesity & metabolism, 2012-10, Vol.14 (s3), p.161-166

2012

Volltextzugriff (PDF)

Fetal sex and maternal risk of pre‐eclampsia/eclampsia: a systematic review and meta‐analysis

BJOG : an international journal of obstetrics and gynaecology, 2017-03, Vol.124 (4), p.553-560

2017

Volltextzugriff (PDF)

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)

Diabetes, obesity & metabolism, 2014-07, Vol.16 (7), p.636-644

2014

Volltextzugriff (PDF)

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Diabetes, obesity & metabolism, 2009-02, Vol.11 (2), p.157-166

2009

Volltextzugriff (PDF)

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme

Diabetes, obesity & metabolism, 2012-01, Vol.14 (1), p.77-82

2012

Volltextzugriff (PDF)

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

Diabetes, obesity & metabolism, 2010-09, Vol.12 (9), p.780-789

2010

Volltextzugriff (PDF)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

The Lancet (British edition), 2006-09, Vol.368 (9541), p.1096-1105

2006

Volltextzugriff (PDF)

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Diabetes, obesity & metabolism, 2013-01, Vol.15 (1), p.42-54

2013

Volltextzugriff (PDF)

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: Update regarding the thiazolidinediones

Diabetologia, 2008-01, Vol.51 (1), p.8-11

2008

Volltextzugriff (PDF)

Clinical predictors and time course of the improvement in β-cell function with short-term intensive insulin therapy in patients with Type 2 diabetes

Diabetic medicine, 2015-05, Vol.32 (5), p.645-652

2015

Volltextzugriff (PDF)

Response to the Letter by Kalra S. et al

The journal of clinical endocrinology and metabolism, 2015-11, Vol.100 (11), p.L118-L118

2015

Volltextzugriff (PDF)

Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk

Diabetes, obesity & metabolism, 2012-09, Vol.14 (9), p.821-825

2012

Volltextzugriff (PDF)

Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus

The New England journal of medicine, 2002-05, Vol.346 (22), p.1685-1691

2002

Volltextzugriff (PDF)

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

Diabetes care, 2000-07, Vol.23 (7), p.962-968

2000

Volltextzugriff (PDF)

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial

Diabetologia, 2012, Vol.55 (1), p.36-45

2012

Volltextzugriff (PDF)

Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes

Diabetologia, 2011-03, Vol.54 (3), p.487-495

2011

Volltextzugriff (PDF)

response to short-term intensive insulin therapy in type 2 diabetes

Diabetes, obesity & metabolism, 2010, Vol.12 (1), p.65-71

2010

Volltextzugriff (PDF)

relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes

Diabetologia, 2010-08, Vol.53 (8), p.1638-1646

2010

Volltextzugriff (PDF)

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

Diabetes, obesity & metabolism, 2015-05, Vol.17 (5), p.477-486

2015

Volltextzugriff (PDF)

Effect of maternal gestational diabetes on the cardiovascular risk factor profile of infants at 1 year of age

Nutrition, metabolism, and cardiovascular diseases, 2013-12, Vol.23 (12), p.1175-1181

2013

Volltextzugriff (PDF)

Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral antidiabetic medications: a pilot study with sitagliptin

Diabetes, obesity & metabolism, 2010-10, Vol.12 (10), p.909-915

2010

Volltextzugriff (PDF)

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

Diabetes care, 2016-10, Vol.39 (10), p.1702-1710

2016

Volltextzugriff (PDF)

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

The New England journal of medicine, 2019-06, Vol.380 (24), p.2295-2306

2019

Volltextzugriff (PDF)

Liraglutide and Renal Outcomes in Type 2 Diabetes

The New England journal of medicine, 2017-08, Vol.377 (9), p.839-848

2017

Volltextzugriff (PDF)

1 – 25 von 280

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(219)

Publikationsform

Artikel
(280)

Sprache

Englisch
(279)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(267)
Female
(246)
Science & Technology
(238)
Life Sciences & Biomedicine
(235)
Adult
(174)
Middle Aged
(165)
Endocrinology & Metabolism
(119)
Biological And Medical Sciences
(112)
Diabetes
(105)
Medical Sciences
(105)
Aged
(79)
Risk Factors
(71)
Endocrinopathies
(62)
Adolescent
(60)
Endocrine Pancreas. Apud Cells
(57)
Diabetes. Impaired Glucose Tolerance
(56)
Blood Glucose - Metabolism
(51)
Hypoglycemic Agents - Therapeutic Use
(46)
Diabetes Mellitus, Type 2 - Drug Therapy
(45)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function

Fetal sex and maternal risk of pre‐eclampsia/eclampsia: a systematic review and meta‐analysis

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: Update regarding the thiazolidinediones

Clinical predictors and time course of the improvement in β-cell function with short-term intensive insulin therapy in patients with Type 2 diabetes

Response to the Letter by Kalra S. et al

Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk

Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial

Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes

response to short-term intensive insulin therapy in type 2 diabetes

relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

Effect of maternal gestational diabetes on the cardiovascular risk factor profile of infants at 1 year of age

Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral antidiabetic medications: a pilot study with sitagliptin

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Liraglutide and Renal Outcomes in Type 2 Diabetes

Aktive Filter

Suchergebnisse filtern